Article 2 Interpretation

In this Order, unless the context requires otherwise—

• “the Act” means the Medicines Act 1968;

• “controlled drug” has the meaning given by section 2 of the Misuse of Drugs Act 1971^f1;

• “marketing authorisation” has the meaning given by regulation 2(4) of the Marketing Authorisations for Veterinary Medicinal Products Regulations 1994^f2;

• “the Misuse of Drugs Regulations” means in relation to England, Wales and Scotland, the Misuse of Drugs Regulations 1985^f3 and, in relation to Northern Ireland, the Misuse of Drugs (Northern Ireland) Regulations 1986^f4;

• “parenteral administration” means administration to an animal by breach of the skin or mucous membrane;

• “prescription only medicine” means a medicinal product of a description or falling within a class specified in article 4 of this Order;

• “repeatable prescription” means a prescription which contains a direction that it may be dispensed more than once;

• “selling” means selling by retail within section 131 of the Act and “sale” has a corresponding meaning;

• “supply” means supply in circumstances corresponding to retail sale within section 131 of the Act;

• “the Merchants Exemption Order” means the Medicines (Exemptions for Merchants in Veterinary Drugs) Order 1998^f5;

and references to a numbered article or Schedule are references to the article or Schedule so numbered in this Order.